# Yun Jing

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yun-jing

- Industry: Healthcare IT
- Headquarters: Shenzhen, China
- Website: www.yunjingzhi.com
- Latest round: Series A (Jun 27, 2023)
- Investors on record: 2

## About

Based in Shenzhen, China and founded in 2015, Yun Jing operates as a hemodialysis SaaS system and integrated service provider, focusing on renal chronic disease management. The company has been awarded as the National High-Tech Enterprise, and has obtained ISO9001 Quality Management System Certification and ISO27001 Information Security Management System Certification. It also has applied 10 Software copyrights. In June 2023, the company completed a series A funding.

The company's main product is a renal chronic disease management service platform. Its information management platform includes haemodialysis, abdominal dialysis and CKD chronic disease management, providing patients with integrated management services from pre-hospital intervention, in-hospital consultation and treatment to post-hospital follow-up. The platforms have multiple platform ports including desktop PC, mobile tablet, WEB management platform, professional forum, mobile APP, and WeChat Public Account.

## Funding rounds

- Series A, Jun 27, 2023 — Richen Capital, Yunkang Investment

## Investors

- Richen Capital (https://capitalatlas.ai/funds/richen-capital) — Series A
- Yunkang Investment — Series A
